Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellula...

por Wu, Chuan Xing, Wang, Xiao Qi, Chok, Siu Ho, Man, Kwan, Tsang, Simon Hing Yin, Chan, Albert Chi Yan, Ma, Ka Wing, Xia, Wei, Cheung, Tan To
Publicado 2018